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Abstract
The moderating influence of binge eating status on obese individuals’ responses to weight loss treatment
was evaluated with a meta-analysis of 36 tests of weight loss treatment (n=792) that were matched to
control key background variables. After controlling for pre-treatment weight, treatment produced more
weight loss in samples of obese non- BED compared with obese BED participants. Weight loss treatment
produced large posttreatment reductions in depression in both obese BED and non-BED samples. The
results indicate that BED status moderated post-treatment weight loss among people in weight treatment
programs. Obese BED (average weight loss= 1.3 kg) samples lost negligible weight compared to obese
non-BED (average weight loss= 10.5 kg) samples. BED status did not moderate psychological responses
to treatment: both BED and non-BED samples experienced large post-treatment reductions in depression.
The clinical implications of these findings are discussed.
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ABSTRACT. The moderating influence of binge eating status on obese individuals’ responses to weight loss treatment was evaluated with a meta-analysis of 36 tests of weight loss
treatment (n=792) that were matched to control key background variables. After controlling
for pre-treatment weight, treatment produced more weight loss in samples of obese nonBED compared with obese BED participants. Weight loss treatment produced large posttreatment reductions in depression in both obese BED and non-BED samples. The results
indicate that BED status moderated post-treatment weight loss among people in weight
treatment programs. Obese BED (average weight loss= 1.3 kg) samples lost negligible weight
compared to obese non-BED (average weight loss= 10.5 kg) samples. BED status did not
moderate psychological responses to treatment: both BED and non-BED samples experienced large post-treatment reductions in depression. The clinical implications of these findings are discussed.
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The prevalence of obesity – defined as
having a body mass index (BMI) greater
than 30 kg/m2 – among adults is about 30%
in the US and slightly less in the UK (1, 2).
Rapid increases in the prevalence of obesity have also occurred in Latin American
and European countries (3, 4). Given the
serious health risks that are associated
with obesity, effective weight loss treatments and programs are in great demand.
Research suggests however that large
scale, permanent weight loss is rare (5).
Even modest weight losses are difficult to
sustain, as over 80% of people who diet for
the purposes of weight loss regain most or
all of the lost weight within a year (6). A
recent meta-analytic review of weight loss
treatments among obese participants
found that weight loss treatment produced
long-term weight loss that averaged about
7% of the average participant’s weight (7).
Despite this modest weight loss, the
review also found that weight loss treatment had robust psychological benefits.
Obese participants in weight loss treatments realized significant post-treatment
reductions in depression, and this

occurred even when participants lost little
or no actual weight.
One question left unaddressed by that
review concerns the moderating influence of
subjects’ binge eating status on their
responses to weight loss treatment. This is
an important clinical question because many
obese people who seek weight loss treatment have clinical or sub-clinical levels of
binge eating disorder (BED) and they may
respond to treatment much differently than
obese people without BED. Binge eating –
eating a greater volume of food than most
other people in a short period of time while
experiencing a loss of control and psychological distress over the eating episode – is
common among obese people (8). BED,
which involves chronic, recurrent, and disruptive binge eating, occurs in about 10% of
obese people (9). However, BED is estimated
to occur in about 30% of obese people in
weight loss programs (10), hence the need to
understand how obese BED and non-BED
individuals respond to weight treatment.
Much research shows that depressive disorders are more common among obese
BEDs than among comparable non-BEDs
(11-14). Research finds that obese BED
compared with obese non-BED people are
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more likely, perhaps as much as six times more
likely, to have a current or past diagnosis of
major depression. Similarly, 51% of obese
BEDs compared with 14% of obese non-BED
subjects met the criteria for major depression
(15-17). Obese BED compared to obese nonBED people are also more likely to meet the
diagnostic criteria for dysthymia, or minor
depression (15). Measures of subclinical levels
of depressive symptoms are consistent with
these findings, with obese BED compared to
obese non-BED subjects consistently reporting
higher depression and lower self-esteem (1821). Even within the obese BED subpopulation,
where restricted variability in binge eating
should attenuate the correlation between binge
eating and depression, increases in binge eating scale scores predict greater depression (22).
The co-morbidity of BED and depression is
relevant to the current investigation because of
evidence showing that depression is more likely a cause than a consequence of changes in
one’s weight. In a large cohort study of over
9,000 adolescent subjects researchers found
that although depression and weight were
unrelated at baseline, depression predicted
weight one year later after controlling for a set
of demographic and behavioral variables (23).
Even among those who were not obese to
begin with, depressed subjects were over two
times more likely than nondepressed subjects
to be obese a year later. Other research shows
that adolescent depression is a better predictor
of adult obesity than adolescent obesity (24).
Still other research suggests that depression
predicts diet relapse (25). If depression causes
weight gain then obese BEDs should fare
worse in obesity treatment and, compared with
obese non-BEDs, should lose less weight in
weight treatment programs.
To summarize, the greater levels of clinical
and subclinical depression in obese BED compared with obese non-BED people suggest that
obese BED people should respond more negatively to weight treatment than obese nonBEDs. Although many tests of weight treatment in the BED subpopulation have been conducted, no quantitative review of these studies
exists. In this study we explored the influence
of BED status on the effectiveness of weight
loss treatment via a matched-study meta-analysis. This method combines the control of a
matched-subject design with the statistical
power of meta-analysis. Weight treatment
studies with obese BED participants were
matched with similar studies using obese nonBED participants such that sample size, the
percentage of females in the sample, sample
age, treatment type, and pre-treatment BMI
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were controlled. The purpose of this study was
to quantify the differences between obese BED
and non-BED individuals’ responses to weight
loss treatment and provide an empirical basis
for commenting on the efficacy of treatment for
these distinct clinical subpopulations. In addition, we sought to validate the role of depression in obese BEDs’ responses to weight treatment by controlling alternative factors that
covary with BED status in weight treatment
programs.

METHOD
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Article identification and matching
procedure
Articles were identified from a larger review
of weight loss treatment effects in obese people. The search parameters for that search,
which yielded 117 weight loss treatment studies, are published and available (7). From those
used in the Blaine et al. (7) review, studies were
included in this review if they evaluated a
weight loss treatment, had a BED grouping
variable, and recorded treatment effects on
either weight or depression. Studies were
excluded if they evaluated a treatment for binge
eating rather than weight loss.
This is not a typical meta-analysis; we have
not exhaustively searched the literature for all
available weight treatment studies with obese
BED and obese non-BED subjects. The goal of
the present method – a matched-study metaanalysis – was control. We sought to isolate the
effect of BED on responses to weight treatment
by matching obese BED and obese non-BED
samples on key variables that covary with BED
status. This matching procedure was done to
rule out alternative explanations for why obese
BED compared with obese non-BED people
might respond differently to weight treatment.
By combining effect sizes across these matched
study pairs, however, we generated considerable statistical power for this analysis.
The matching procedure started with a BED
sample and paired it with a non-BED sample
with comparable sample size, percentage of
females in the sample, sample mean age, treatment type, and mean sample pre-treatment
BMI. When studies included both BED and
non-BED samples in their weight treatment
program, the non-BED sample was usually the
best match for the BED sample. In studies that
tested weight treatment in a sample of BED
subjects without a non-BED control group, the
matching non-BED sample was found from
another article. When two levels of BED status
were included in a study (e.g., moderate and
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severe BED samples), matching non-BED samples were found for each. The pairs of matched
studies are presented in Table 4. Of the 16 BED
samples, 10 were identified using scores on the
Binge Eating Scale (26). The remaining 6 samples identified BED subjects with the
Questionnaire on Eating and Weight Patterns –
Revised (11), which contains items that assess
DSM-IV diagnostic criteria for BED, or an ad
hoc DSM-IV diagnostic criteria-based measure.
Article coding
Articles were coded for the following variables: sample size, percentage of females in the
sample, sample mean age, treatment duration,
treatment type (whether the treatment was
generally drug/surgery-based or psychotherapy-based), sample mean pre-treatment BMI,
sample mean pre-treatment depression (BDI or
Beck Depression Inventory) score, and percentage of attrition from treatment. Effect size statistics were recorded for the effect of treatment
on post-treatment weight loss and depression.
Effects size statistics reported in the articles
(typically pre- and post-treatment means/SDs
or a t, F, or p level from a pre- vs post-treatment significance test) were converted to rs for
analysis. The effects were analyzed with Metaanalysis 5.3 (27).

Responses to weight loss

BED samples. In addition to the matched variables, then, these analyses control treatment
duration and attrition as possible artifacts of
group differences in response to weight treatment. The data also contradict findings that
BED is a risk factor for attrition in weight treatment programs (31).
Weight loss
Summary statistics for the effects of weight
loss treatment on weight separated by sample
type are presented in Table 2. Weight loss
treatment produced weight loss in both BED
and non-BED samples, but the size of the treatment effect on weight in non-BED samples in
standard deviation units (g= -1.48) was nearly
four times the size of the effect in BED samples
(g= -0.40. These effect sizes are equivalent to
average weight losses of 3.4 lbs (1.5 kg) and
23.5 lbs (10.7 kg) in BED and non-BED samples,
respectively. Estimating from the average body
mass indexes for each group listed in Table 1
this represents an average post-treatment
weight loss of about 2% and 11% of body
weight in obese BED and obese non-BED samples, respectively. These results are striking
given that pretreatment weight, treatment
duration, treatment type, and attrition – each a
plausible alternative explanation for the group
difference – were controlled.
The homogeneity test of sample effect sizes
in the non-BED samples indicated the likely
influence of a moderating variable or variables. The possible moderating influence of
treatment type was dismissed upon inspecting
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RESULTS
The data from 16 obese BED samples (total
n=388) and 16 matched obese non-BED samples (total n=465) were analyzed. Of these 16
matched sample pairs 13 reported effect sizes
for both post-treatment weight loss and
depression; the remaining 3 studies reported
effect sizes on one outcome (see Table 4 for
descriptive statistics for studies in review). To
determine if the BED and non-BED studies
were equivalent on the matched variables, significance tests compared sample size, females
as a percentage of the sample, sample age,
treatment duration, and pretreatment sample
BMI scores across the sample type (Table 1).
These results show that the matching procedure was effective: BED and non-BED samples
were not significantly different on each of the
matched variables. Pre-treatment BDI, treatment duration, and attrition rate were not
matched variables but were nonetheless compared across sample type. The results (Table 1)
show that the treatment duration and attrition
rates for obese BED compared to non-BED
samples were also not significantly different.
However, BED samples were significantly
more depressed before treatment than non-
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TABLE 1
Comparison of subject characteristics in BED and matched non-BED
samples in weight loss treatment studies.
Sample type
BED

non-BED

t-test of mean
diff. (2-tailed)

Sample size (n)

21.0 (20.5)

30.9 (33.8)

p=0.17

Percentage female

96.8 (7.1)

96.0 (7.1)

p=0.88

Age (years)

41.1 (3.6)

40.8 (3.2)

p=0.61

Pretreatment BMI (kg/m2)

35.1 (5.7)

36.2 (5.7)

p=0.62

3
13

3
13

3.6 (1.3)

5.3 (4.1)

Treatment type:
DS studies
PT studies
Treatment duration (months)
Attrition rate

20.8% (18.5) 18.0% (17.7)

Pre-treatment BDI

15.1 (3.8)

8.8 (2.3)

p=0.12
p=0.66
p<0.01

DS= drug/surgery-based treatment; PT= psychotherapy-based treatment;
BMI= body mass index; BDI= Beck Depression Inventory.
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TABLE 2
Summary meta-analytic statistics for the effects of weight loss treatment on weight loss and depression in obese BED
and obese non-BED samples.
BED samples
Weight loss

non-BED samples

Depression

Weight loss

Depression

k

15

14

15

14

n

329

279

463

319

Unweighted mean r

-0.22

-0.40

-0.40

-0.42

Pop. effect size (weighted r)
95% CI of weighted r

100%

100%

18%
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p=0.54

p=0.58

p<0.001

p=0.42

-0.20

-0.42

-0.59

-0.21 to -0.19

-0.43 to -0.41

-1.1 to -0.10

-0.40

-0.92

-1.48

Mean standardized diff. (g)

-0.46
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Percent of observed variance due to sampling error
Test of homogeneity (χ2)

-0.47 to -0.45
-1.05

100%

k= number of samples, n= total sample size across k samples, CI= confidence interval, χ2 df= k-1.

the effect sizes for psychotherapy-based (PT)
compared to drug/surgery-based (DS) treatment effects. The heavily overlapping range of
effect sizes in PT (0.00 to -0.90) and DS (-0.23 to
-0.82) samples did not suggest treatment type
moderation. The moderating influence of pretreatment sample BMI was explored by first
separating samples by the median BMI (36
kg/m 2 ) to create two groups of studies of
roughly equal size. In seven out of the eight
moderately obese (BMI<36 kg/m 2 ) samples
weight effect sizes ranged -0.02 to -0.30,
whereas in five of the seven extremely obese
(BMI≥36 kg/m2) samples the effect sizes ranged
from -0.51 to -0.90. Based on these non-overlapping ranges, weight effect sizes in non-BED
samples were meta-analyzed separately by
BMI sample type. The results (Table 3) confirm
the moderating influence of pre-treatment
obesity level: the average post-treatment
weight loss in extremely obese samples was
over three times larger than in moderately
obese samples. Was this effect an artifact of
attrition? The attrition rates of moderately
(12.1%) and extremely (18.2%) obese non-BED
samples were not significantly different and in
the wrong direction to account for the greater
weight loss among the most obese samples.

reduction of depression by 3.3 and 2.6 BDI
points for BED and non-BED samples, respectively. Given that pre-treatment BDI was not
controlled through the study-matching procedure used in this review, and thus covaries
with BED status, perhaps the slightly smaller
treatment effect on depression among nonBED samples is due to a floor effect in those
studies. The pre-treatment BDI means in Table
1 suggest otherwise: non-BED samples were
moderately depressed at the start of treatment
(average BDI score= 9.2) with plenty of room
for reductions of the magnitude observed in
the BED samples. Thus, it does not appear that
the modest difference between BED and non-

TABLE 3
Summary meta-analytic statistics for the effects of weight loss
treatment on weight loss in moderately and extremely obese
non-BED samples.
Moderately obese
(BMI<36)
k

8

7

n

125

338

Unweighted mean r

-0.32

-0.55

Pop. effect size (weighted r)

Depression
Summary statistics for the effects of weight
loss treatment on depression separately by
sample type are presented in Table 2. Weight
loss treatment produced significant and large
reductions in depression in both BED and nonBED samples, with effect sizes around one
standard deviation in both groups. In clinical
terms this effect size is equivalent to an average
57
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Extremely obese
(BMI≥36)

-0.31

-0.72

-0.32 to -0.30

-1.08 to -0.35

Mean standardized diff. (g)

-0.65

-2.06

Percent of observed variance
due to sampling error

100%

12%

p=0.66

p<0.01

95% CI of weighted r

Test of homogeneity (χ2)

k= number of samples, n= total sample size across k samples, CI= confidence
interval, χ2 df=k-1, BMI= body mass index.
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Responses to weight loss

BED samples’ post-treatment depression is an
artifact of pretreatment differences in depression between BED and non-BED samples.
Did treatment effects on depression depend
on having lost weight? Post-treatment weight
loss and depression effects were uncorrelated

(r(25)=0.03, p>0.05) indicating that the benefits
of treatment for weight and depression were
independent. This is consistent with the findings of a larger review of weight treatment
studies in which post-treatment reductions in
depression occurred even in samples with little

TABLE 4
Descriptive statistics and effect sizes of reviewed studies presented in matched-study pairs.
Study #/Study (ref)

Sample
type

n

%
female

Age

PreBMI

PreBDI

Treat.
dur.

Attrit.
rate

u
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type

WL

Dep

PT

-0.04

0.12

PT

-0.27

-0.53

1A Porzelius et al. (28)

BED

10

100

38

31

7.2

4

10%

1B Porzelius et al. (28)

non-BED

8

100

38

31

10

4

12%

2A Porzelius et al. (28)

BED

8

100

38

31

10

4

12%

PT

-0.27

-0.15

2B Porzelius et al. (28)

-0.23

-0.64

non-BED

8

100

38

31

7.5

4

12%

PT

3A Jirik-Babb & Geliebter (18)

BED

21

100

44

31

10.1

1

67%

PT

-0.25

3B Jirik-Babb & Geliebter (18)

non-BED

22

100

44

35

4.6

1

64%

PT

-0.19

4A Malone & Alger-Mayer (29)

BED

31

79

44

48

12

6

42%

DS

-0.43

4B Malone & Alger-Mayer (29)

non-BED

52

79

46

48

9

6

52%

DS

-0.51

5A Alger et al. (30)

BED

17

82

45

40

12.7

3

0%

DS

-0.18

5B Alger et al. (30)

non-BED

16

88

45

37

10

3

6%

DS

-0.23

-0.53

BED

9

100

38

31

14.5

4

22%

PT

-0.30

-0.27

non-BED

17

100

39

31

7.7

2.5

18%

PT

-0.27

-0.55

7A Agras et al. (32)

BED

93

100

46

37

14.9

9

18%

PT

0.00

-0.34

7B Gladis et al. (33)

non-BED

50

100

41

36

11.3

6

14%

PT

-0.81

-0.60

8A Porzelius et al. (28)

BED

11

100

38

31

15

4

18%

PT

-0.15

-0.40

8B Sbrocco et al. (34)

non-BED

12

100

39

33

6.75

12

8%

PT

-0.67

-0.14

9A Fossati et al. (35)

BED

23

100

42

34

16

3

3%

PT

-0.24

-0.51

non-BED

21

88

43

36

10.1

3

19%

PT

-0.60

-0.38

6A Porzelius et al. (28)
6B Marcus et al. (31)

9B Wadden et al. (22)
10A Fossati et al. (35)

-0.50

BED

25

100

37

36

16

3

3%

PT

-0.45

-0.71

10B Wadden et al. (22)

non-BED

28

100

37

40

13.2

3

18%

PT

-0.90

-0.32

11A Marcus et al. (31)

BED

17

100

39

31

17.5

2.5

23%

PT

-0.27

-0.59

11B Rippe et al. (36)

non-BED

40

100

37

32

3

25%

PT

-0.30

-0.41

12A Marcus et al. (31)

BED

18

100

39

31

17.5

2.5

28%

PT

-0.21

-0.59

12B Marcus et al. (31)

non-BED

17

100

39

31

7.7

2.5

0%

PT

-0.18

-0.55

19

13A Malone & Alger-Mayer (29)

BED

26

88

45

48

non-BED

100

85

41

49

14A Nauta et al. (38)

BED

21

100

38

33

14B Nauta et al. (38)

non-BED

21

100

38

15A Nauta et al. (38)

BED

16

100

38

15B Nauta et al. (38)

non-BED

16

100

38

BED

13

100

46

36

non-BED

8

100

45

38

13B Guisado et al. (37)

16A Fossati et al. (35)
16B Hayward et al. (39)

6

50%

DS

-0.56

18

0%

DS

-0.82

19.2

3.75

14%

PT

-0.04

-0.50

33

8.4

3.75

10%

PT

-0.23

-0.13

33

19.3

3.75

19%

PT

-0.19

-0.40

33

7.3

3.75

12%

PT

-0.02

-0.30

20

3

3%

11

6

PT

0.00

-0.45

PT

0.00

-0.58

BED= Binge eating disorder; Pre-BMI= Mean sample BMI before treatment; Pre-BDI= Mean sample Beck Depression Inventory score before treatment;
Treat Dur= Length of treatment in months; Attrit Rate= Percentage of sample lost before post-treatment measurement; Treat Type= Treatment type:
Psychotherapy-based (PT) or Drug/surgery-based (DS); WL= Treatment effect size (r) on weight (negative rs indicate lower post-treatment compared to
pre-treatment weight); Dep= Treatment effect size (r) on depression (negative rs indicate lower post-treatment compared to pre-treatment depression).
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or no weight loss (see Blaine et al., in press). It
also is in keeping with an understanding of
depression as causally prior to weight change –
that is, causing weight gain but not responsive
to weight loss.

CONCLUSION
Binge eating status moderated weight loss
treatment effects on weight but not depression. In a quantitative analysis of obese BED
and non-BED samples in weight treatment,
post-treatment weight loss was much smaller
in obese BED than in obese non-BED samples. Indeed, obese BED individuals’ average
post-treatment weight loss (3.3 lbs/1.5 kg or
2% of their body weight over about 3 1/2
months of treatment) hardly justifies the
expense of weight treatment. Subjects in nonBED samples responded positively to treatment (losing, on average, 11% of their body
weight) and the benefits were greater among
samples of extremely compared with moderately obese people. Thus, the chief clinical
implication of this review is that BED is a risk
factor for poor responses to weight treatment,
at least where weight loss is concerned.
Whether the poor post-treatment weight loss
in obese BED samples is due to initial weight
loss followed by regain, or simply failure to
lose weight at all, cannot be determined from
this analysis. However, research that does
find an association between BED status and
weight regain after loss (40) suggests that
weight cycling, even within the duration of a
weight treatment program, is more likely in
BEDs than non-BEDs. Research documents
greater weight cycling in general among
obese BED than obese non-BED people (19,
41). The proclivity to weight cycle complicates
obese BEDs’ response to weight treatment
and represents a real health risk associated
with weight treatment.
Because this analysis controlled several factors that were plausibly related to responses to
weight treatment (i.e., pre-treatment BMI,
treatment type, treatment duration, attrition
rate), their influence on the treatment effect is
controlled. Of these variables that routinely
covary with BED status, controlling the effects
of treatment type presented the greatest challenge. Treatments that are designed for obese
BEDs compared with obese people with no
binge eating symptoms are often much different, and only the most basic categorization
scheme (drug/surgery-based vs. psychotherapy-based could be used to match studies on
treatment type. Caution is appropriate, there-
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fore, in concluding that treatment type is completely ruled out as a possible cause of the
treatment effects. Although this study did not
test an explanatory hypothesis, these controls
nevertheless make it more likely that the explanation for obese BEDs’ poor weight loss lies in
their greater levels of depression.
Despite negligible weight loss among obese
BED samples, they did realize psychological
benefits from treatment. The effects of weight
treatment for post-treatment reductions in
depression were equally large for obese BED
and obese non-BED samples. Most of the studies in this review used weight treatments that
combined diet, exercise, and nutritional components with cognitive-behavioral therapy.
Given that weight loss was not a prerequisite
for reductions in depression, it is reasonable to
conclude that the psychotherapeutic elements
of weight treatment are effective and worthwhile in the obese non-BED population.
Among obese BEDs, however, the clinician
must balance the psychological benefit of
weight treatment in the form of greatly
reduced depression with the poor prospects for
reducing weight.
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